UNSPSC 51286902: Cinoquidox

This classification denotes a topical anti-infective agent with the molecular formula C13H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5743F6U086, chemically known as n-(2-cyanoethyl)-3-methyl-2-quinoxalinecarboxamide 1,4-dioxide. but more generally known as cinoquidox, which bears US NIH Compound Identifier 193984. European Medicines Agency schedules Cinoquidox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06308MIG.

The term CINOQUIDOX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 33, No. 10 1979, List 19). CINOQUIDOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O=[N]1C(C(N(O)C2C1CCCC2)C)C(=O)NCCC#N.

UNSPSC 51286902 Cinoquidox is a Commodity code that does not align with the state and local procurement activity posted under it. The code's nominal scope—cinoquidox, a quinoxaline antibiotic—bears no relation to the four recent solicitations, which cover naloxone and drug deactivation systems, direct-to-manufacturer pharmacy prescriptions, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and over-the-counter products. The mismatch suggests either a data-tagging error in the source records or that the code is being applied inconsistently across state and local procurement systems. The issuing bodies include a county health department (Seminole County, Florida), a state health commission (Texas HHS), a city fire department (Tampa), and a cooperative purchasing alliance administered by a state department of administration (Minnesota MMCAP). The recent solicitations emphasize pharmaceutical procurement, medical supplies for emergency response, and pharmacy benefit management across health systems and government employee plans.

Activity is concentrated in Florida, Texas, Minnesota, and Oregon, with the most recent opportunities spanning January through June 2026. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (a historical date that appears to be a data artifact); the contract includes a two-year term with one-year renewal option and is potentially FEMA-funded. The City of Tampa posted IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated value of $700,000.00 and a sheltered-market set-aside for certified Small Local Business Enterprises at a 5% bid discount not to exceed $10,000. Minnesota MMCAP issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with proposals due March 26, 2026, and a contract effective date of July 1, 2026. Texas HHS posted RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, signaling future formal procurement to follow the information-gathering phase.